228 related articles for article (PubMed ID: 15341780)
1. The quiet revolution: outsourcing in pharma.
Crossley R
Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
[No Abstract] [Full Text] [Related]
2. Outsourcing lead optimisation--the quiet revolution.
Clark DE; Newton CG
Drug Discov Today; 2004 Jun; 9(11):492-500. PubMed ID: 15149625
[TBL] [Abstract][Full Text] [Related]
3. Outsourcing lead optimization: the eye of the storm.
Clark DE
Drug Discov Today; 2011 Feb; 16(3-4):147-57. PubMed ID: 21145413
[TBL] [Abstract][Full Text] [Related]
4. A quiet revolution in lead optimisation services?
Cavalla D
Drug Discov Today; 2004 Aug; 9(15):635-6. PubMed ID: 15279844
[No Abstract] [Full Text] [Related]
5. Clinical trials in India.
Maiti R; M R
Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
[TBL] [Abstract][Full Text] [Related]
6. Biomanufacturing, from bust to boom...to bubble?
Thiel KA
Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
[No Abstract] [Full Text] [Related]
7. Pharmaceutical futures: made in China?
Cyranoski D
Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994
[No Abstract] [Full Text] [Related]
8. Outsourcing clinical trials.
Hanauer SB
Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):191. PubMed ID: 19347005
[No Abstract] [Full Text] [Related]
9. Bioanalytical outsourcing: transitioning from Pharma to CRO.
Hayes R
Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
[No Abstract] [Full Text] [Related]
10. India's growing participation in global clinical trials.
Gupta YK; Padhy BM
Trends Pharmacol Sci; 2011 Jun; 32(6):327-9. PubMed ID: 21489644
[TBL] [Abstract][Full Text] [Related]
11. Chinese manufacturers vie for piece of outsourcing pie.
Jia H
Nat Biotechnol; 2007 Dec; 25(12):1337-8. PubMed ID: 18066012
[No Abstract] [Full Text] [Related]
12. Biopharma CRO industry in China: landscape and opportunities.
Xia C; Gautam A
Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
[TBL] [Abstract][Full Text] [Related]
13. Bioanalytical outsourcing models in pharmaceutical companies.
Zimmer D
Bioanalysis; 2017 Aug; 9(15):1145-1148. PubMed ID: 28763250
[No Abstract] [Full Text] [Related]
14. Schrödinger's pipeline and the outsourcing of pharmaceutical innovation.
McMeekin P; Lendrem DW; Lendrem BC; Pratt AG; Peck R; Isaacs JD; Jones D
Drug Discov Today; 2020 Mar; 25(3):480-484. PubMed ID: 31835019
[TBL] [Abstract][Full Text] [Related]
15. Bioanalytical outsourcing strategy in China.
Dong K; Tang D
Bioanalysis; 2017 Aug; 9(15):1157-1159. PubMed ID: 28763245
[No Abstract] [Full Text] [Related]
16. Meeting the challenges of bioanalytical outsourcing: understanding the hidden cost of price pressure.
Bennett P
Bioanalysis; 2011 Nov; 3(22):2491-3. PubMed ID: 22122596
[No Abstract] [Full Text] [Related]
17. Outsourcing is in.
Landhuis E
Nature; 2018 Apr; 556(7700):263-265. PubMed ID: 29643487
[No Abstract] [Full Text] [Related]
18. Outsourcing lead optimization: constant change is here to stay.
Clark DE
Drug Discov Today; 2007 Jan; 12(1-2):62-70. PubMed ID: 17198974
[TBL] [Abstract][Full Text] [Related]
19. Bioanalytical outsourcing: the two sides of the medal.
Zimmer D
Bioanalysis; 2013 Sep; 5(17):2095-9. PubMed ID: 23962249
[No Abstract] [Full Text] [Related]
20. Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model.
Abberley L
Bioanalysis; 2017 Aug; 9(15):1139-1144. PubMed ID: 28762760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
